Changes between Version 55 and Version 56 of NIAID2022

Timestamp:

Feb 9, 2023, 2:01:18 PM (3 years ago)

Author:

Elaine Meng

Comment:

--

NIAID2022

@@ -71 +71 @@
 One outstanding issue is that travel costs are treated as a separate line item.  Has Darrell planned for this expense too?  Meghan will talk to him about it.  Scooter will work on generating an estimate.
 
+More discussion of measurables for VR vs. desktop study.  Kristen: what is the added value?  Enhanced discovery, engagement, ... Scooter: some aspects are qualitative rather than quantitative. Tom G: somewhat skeptical of this study, most benefits are to experts looking at their own data, rather than better learning by naive users.  Scooter: who are the test subjects?  Naive users or experts?  Elaine: doesn't "pedagogical" imply students?  Scooter: we may have moved beyond that initial wording, could decide that the audience is experts instead. Phil: same kind of idea as surgeons changing their surgery plans after VR visualization.  But where I've seen VR be especially useful is for scientist researchers who are experts in a particular protein system but not in structural biology.  Maybe biochemists or cell biologists. Scooter: figure out audience first, then the questions/problems. Kristen: what is the motivation?  Scooter (trying to channel Darrell): NIAID has invested in this great BioViz lab with VR capabilities; what value does that bring to its researchers, does it further the mission of NIAID.  Kristen: don't want to make the study group extremely narrow just to get the results you want.  Do 2 or 3 groups: postdocs, experts, etc.  Elaine: is it hard to get enough subjects to power such a study?  Scooter: we rely on Andy to figure that out, but we can learn even from fairly small groups.
+
 == 2/2/2023 ==